These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 8281530

  • 1. Glucose and lipid metabolism in essential hypertension: effects of diuretics and ACE-inhibitors.
    De Cesaris R, Ranieri G, Filitti V, Andriani A, Lamontanara G.
    Cardiology; 1993; 83(3):165-72. PubMed ID: 8281530
    [Abstract] [Full Text] [Related]

  • 2. Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients.
    Fogari R, Zoppi A, Malamani GD, Marasi G, Vanasia A, Villa G.
    Br J Clin Pharmacol; 1995 May; 39(5):471-6. PubMed ID: 7669481
    [Abstract] [Full Text] [Related]

  • 3. Effects of angiotensin-converting enzyme inhibitors on glucose and lipid metabolism in essential hypertension.
    Oksa A, Gajdos M, Fedelesová V, Spustová V, Dzúrik R.
    J Cardiovasc Pharmacol; 1994 Jan; 23(1):79-86. PubMed ID: 7511740
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the hemodynamic and metabolic effects of low-dose hydrochlorothiazide and lisinopril treatment in obese patients with high blood pressure.
    Reaven GM, Clinkingbeard C, Jeppesen J, Maheux P, Pei D, Foote J, Hollenbeck CB, Chen YD.
    Am J Hypertens; 1995 May; 8(5 Pt 1):461-6. PubMed ID: 7662221
    [Abstract] [Full Text] [Related]

  • 5. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M, Richter WO, Schwandt P, Holzgreve H.
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [Abstract] [Full Text] [Related]

  • 6. Plasma lipid profiles and antihypertensive agents: effects of lisinopril, enalapril, nitrendipine, hydralazine, and hydrochlorothiazide.
    Williams LL, Lopez LM, Thorman AD, Quay GP, Stein GH, Mehta JL.
    Drug Intell Clin Pharm; 1988 Jun; 22(7-8):546-50. PubMed ID: 2843341
    [Abstract] [Full Text] [Related]

  • 7. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension.
    Pollare T, Lithell H, Berne C.
    N Engl J Med; 1989 Sep 28; 321(13):868-73. PubMed ID: 2671740
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the effects of atenolol and nifedipine on glucose, insulin, and lipid metabolism in patients with hypertension.
    Sheu WH, Swislocki AL, Hoffman B, Chen YD, Reaven GM.
    Am J Hypertens; 1991 Mar 28; 4(3 Pt 1):199-205. PubMed ID: 2043298
    [Abstract] [Full Text] [Related]

  • 9. The effects of thiazide diuretics upon plasma lipoproteins.
    Johnson BF, Saunders R, Hickler R, Marwaha R, Johnson J.
    J Hypertens; 1986 Apr 28; 4(2):235-9. PubMed ID: 3519766
    [Abstract] [Full Text] [Related]

  • 10. Lisinopril is neutral to insulin sensitivity and serum lipoproteins in essential hypertensive patients.
    Thürig C, Böhlen L, Schneider M, de Courten M, Shaw SG, Riesen W, Weidmann P.
    Eur J Clin Pharmacol; 1995 Apr 28; 49(1-2):21-6. PubMed ID: 8751016
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the effects of nicardipine and metoprolol on lipid and glycidic metabolism in hypertensive subjects.
    De Cesaris R, Ranieri G, Filitti V, Bonfantino MV, Dentamaro M, Andriani A.
    Int J Clin Pharmacol Res; 1991 Apr 28; 11(6):275-82. PubMed ID: 1823085
    [Abstract] [Full Text] [Related]

  • 12. Abnormalities of carbohydrate and lipid metabolism in patients with hypertension.
    Fuh MM, Shieh SM, Wu DA, Chen YD, Reaven GM.
    Arch Intern Med; 1987 Jun 28; 147(6):1035-8. PubMed ID: 3296980
    [Abstract] [Full Text] [Related]

  • 13. Metabolic parameters after changing from hydrochlorothiazide to verapamil treatment in hypertension.
    Lehtonen A, Gordin A.
    Eur J Clin Pharmacol; 1984 Jun 28; 27(2):153-7. PubMed ID: 6389153
    [Abstract] [Full Text] [Related]

  • 14. Effects of doxazosin and hydrochlorothiazide on lipid levels in Korean patients with essential hypertension.
    Jones DW, Sands CD.
    J Cardiovasc Pharmacol; 1993 Sep 28; 22(3):431-7. PubMed ID: 7504134
    [Abstract] [Full Text] [Related]

  • 15. [The antihypertensive effects of the lisinopril-hydrochlorothiazide combination (Zestoretic) in elderly hypertensive patients. The results of a multicenter study. The Italian Zestoretic Study Group].
    Mancia G.
    Minerva Cardioangiol; 1994 Oct 28; 42(10):483-91. PubMed ID: 7816237
    [Abstract] [Full Text] [Related]

  • 16. Effects of indapamide versus hydrochlorothiazide on plasma lipids and lipoproteins in hypertensive patients: a direct comparison.
    Spence JD, Huff M, Barnett PA.
    Can J Clin Pharmacol; 2000 Oct 28; 7(1):32-7. PubMed ID: 10822211
    [Abstract] [Full Text] [Related]

  • 17. Urapidil compared with diuretics in the treatment of mild-to-moderate essential hypertensive patients: effects on glucose metabolism, insulin sensitivity, and lipid profile.
    De Lima MD, Kohlmann NE, Neves FA, Zanella MT, Ribeiro AB, Kohlmann O.
    Blood Press Suppl; 1994 Oct 28; 4():53-6. PubMed ID: 7804514
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of lisinopril or lisinopril/hydrochlorothiazide compared with adjusting of previous medication and intensifying non-pharmacological treatment in patients with mild to moderate hypertension.
    Keinänen-Kiukaanniemi S, Rasmusen M, Pekkarinen T, Pitkäjärvi T, Romo M, Takala J.
    Arzneimittelforschung; 1997 Feb 28; 47(2):144-50. PubMed ID: 9079233
    [Abstract] [Full Text] [Related]

  • 20. Weight reduction versus antihypertensive drug therapy in obese men with high blood pressure: effects upon plasma insulin levels and association with changes in blood pressure and serum lipids.
    Fagerberg B, Berglund A, Andersson OK, Berglund G.
    J Hypertens; 1992 Sep 28; 10(9):1053-61. PubMed ID: 1328365
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.